Alpha Aesthetics Partners Expands Northern Virginia Presence with Addition of Blossom Medical to the Refined Aesthetics Team

SACRAMENTO, Calif., Aug. 20, 2025 /PRNewswire/ — Alpha Aesthetics Partners, a leader in the medical aesthetics industry and a portfolio company of the Thurston Group, is proud to announce that Blossom Medical, a highly regarded aesthetics practice in Winchester, Virginia, has joined the Refined Aesthetics team, led by Sarah Safa, MS, PA-C. This addition marks Alpha’s continued […]

The Virga Law Firm Launches Episode 16 of The Florida Family Law Attorney Podcast Featuring Rebecca Perra of Our Family Wizard

PANAMA CITY, Fla., Aug. 20, 2025 /PRNewswire/ — The Virga Law Firm proudly announces the release of Episode 16 of its ongoing family law podcast series, featuring a compelling conversation between managing attorney Gerard Virga and Rebecca Perra, Judicial Education Coordinator at Our Family Wizard—a leading co-parenting technology platform used across the United States. Released on Friday, […]

Lockheed Martin Corporation Stock News: LMT Investors with Large Losses Should Contact Robbins LLP for Information About Leading the LMT Class Action Lawsuit

SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Lockheed Martin Corporation (NYSE: LMT) securities between January 23, 2024 and July 21, 2025. Lockheed Martin is an aerospace defense company. For more information, submit a form, email attorney Aaron Dumas, […]

Sable Offshore Corp. Stock News: SOC Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Class Action Lawsuit Against SOC

SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Sable Offshore Corp. (NYSE: SOC) securities between May 19, 2025 and June 3, 2025 and/or traceable to the Company’s May 21, 2025 secondary public offering (“SPO”).  Sable Offshore operates in […]

Flywire Corporation Stock News: FLYW Investors with Large Losses Should Contact Robbins LLP for Information About Leading the FLYW Class Action Lawsuit

SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Flywire Corporation (NASDAQ: FLYW) securities between February 28, 2024 and February 25, 2025. Flywire operates as a payments-enablement and software company in the U.S. and internationally. For more information, submit […]

AskNewt Unveils Version 3.0, Bringing Trusted, Accurate, Smarter, Faster, and More Personalized AI Insights to Finance and Everyday Life

The latest release introduces real-time, context-aware analysis, secure portfolio tools, and persistent memory — delivering sharper answers and a safer, more personalized user experience. NEW YORK, Aug. 20, 2025 /PRNewswire/ — AskNewt, a leading provider of AI-powered financial and personal insights, today announced the upcoming release of AskNewt Version 3.0, the company’s most advanced platform […]

National Press Club to Honor Imprisoned Chinese Journalist Dong Yuyu with President’s Award; Renews Call for His Release

WASHINGTON, Aug. 20, 2025 /PRNewswire/ — The National Press Club announced today it will present its distinguished President’s Award for 2025 to Chinese journalist Dong Yuyu, a respected editor and columnist who has been imprisoned in Beijing since February 2022 after being convicted on espionage charges he is appealing. “Journalism is not espionage. Dong Yuyu is being […]

HDAC Inhibitors Market Sees Upward Trajectory Across the 7MM During the Forecast Period (2025-2034) Driven by Innovation in Cancer Therapies | DelveInsight

The HDAC inhibitor pipeline remains active, with several next-generation agents advancing in clinical trials. Abexinostat (Xynomic Pharmaceuticals) is in Phase III development for renal cell carcinoma, representing a potential expansion into solid tumors. Quisinostat (Viriom) is in Phase II for uveal melanoma, and Entinostat, partnered between EOC Pharma and Syndax, is being explored in Hodgkin […]